Not checkedNot checked for notices yet.
COVID-19: long-term health impacts
Karine R. Badalyan, Ella Iu. Solovyeva
Consilium Medicum · 2021
doi:10.26442/20751753.2021.12.201347 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Several studies have recently been conducted showing persistent COVID-19 symptoms in patients recovering after the acute phase of the disease. Energy imbalance plays a leading role in the pathogenesis of post-COVID syndrome. The choice of a metabolic cytoprotection drug with anti-asthenic activity will be decisive for the further tactics of managing the patient not only in the hospital, but also during the entire further period of recovery after the infection.
Abstract licence: CC BY
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.